---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-24-000030"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2024-02-20T23:59:59+00:00"
generated_at: "2026-06-05T22:46:02.953549+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Globus Medical Q4 net sales $616.5M (+124.6% YoY); non-GAAP EPS $0.60; reaffirms FY2024 guidance

## Summary
- Q4 net sales $616.5M, +124.6% as-reported (+123.8% constant currency); driven by NuVasive merger and organic growth.
- GAAP net income $15.0M (diluted EPS $0.11) down 70% YoY due to acquisition costs; non-GAAP diluted EPS $0.60 (+2.1%).
- Full year 2023 net sales $1,568.5M (+53.3%); GAAP EPS $1.07; non-GAAP EPS $2.32.
- Legacy Globus organic revenue grew 10.8% in Q4 and 12.8% for full year vs prior year.
- FY2024 guidance reaffirmed: net sales $2.450B-$2.475B; non-GAAP EPS $2.68-$2.70.

## SEC filing metadata
- accession: 0001562762-24-000030
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2024-02-20T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000156276224000030/0001562762-24-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000156276224000030/gmed-20240220x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-24-000030
- JSON: https://secwatch.observer/filing/0001562762-24-000030.json
- Plain text: https://secwatch.observer/filing/0001562762-24-000030.txt

## Key facts
- Earnings Releases
  GLOBUS MEDICAL INC reported the fourth quarter ended December 31, 2023 results: revenue $ 616.5 million, net income $ 15.0 million, EPS $0.11.
  - Period: the fourth quarter ended December 31, 2023
  - Revenue: $ 616.5 million
  - Net income: $ 15.0 million
  - EPS: $0.11
  - Result: reported results
  source text: Worldwide net sales for the fourth quarter were $ 616.5 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1237831/000156276224000030/0001562762-24-000030-index.htm
- Earnings Releases
  GLOBUS MEDICAL INC reported the fiscal year ended December 31, 2023 results: revenue $ 1,568.5 million, net income $ 122.9 million, EPS $1.07. Guidance reaffirmed.
  - Period: the fiscal year ended December 31, 2023
  - Revenue: $ 1,568.5 million
  - Net income: $ 122.9 million
  - EPS: $1.07
  - Guidance: reaffirmed
  - Result: reported results
  source text: EPS ”) was $0. 11 and non-GAAP diluted EPS was $0. 60 · Non-GAAP adjusted EBITDA was $ 1 70.0 million, or 27. 6 % of net sales  Full Year 20 2 3 : · Worldwide net sales were $ 1,568.5 million , an increase of 53.3% on an actual and constant currency basis · GAAP n et income for the year was $ 122.9 million · GAAP d iluted EPS was $ 1.07 and n on-GAAP diluted EPS was $
  evidence_url: https://www.sec.gov/Archives/edgar/data/1237831/000156276224000030/0001562762-24-000030-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.